Healio

Serum testosterone levels vary throughout day following transdermal application

Please provide your email address to receive an email when new articles are posted on . In a randomized double blind, placebo-controlled trial with older men assigned either AndroGel 1% (transdermal ...

ARSYNL Rx Introduces First Needle-Free Testosterone HypoSpray® for Men and Women

ARSYNL Rx Launches Exclusive HypoSpray® Transdermal Testosterone Option, Marking a New Era in Hormone Support Dover, United ...
New Atlas

Can testosterone improve cognition in older women?

For women, the onset of midlife brings with it an array of distressing symptoms related to changes in hormone levels. The risk of dementia increases with age – particularly after the mid-60s – memory ...
Nature

To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application

There is still considerable controversy concerning the role of androgen therapy for hypoactive sexual desire disorder in females. Clinical trials have shown that exogenous testosterone therapy ...
Healio

FDA calls for labeling changes, medication guides for two topical testosterone gels

Please provide your email address to receive an email when new articles are posted on . The FDA announced that it is requiring manufacturers of two prescription topical testosterone gel products, ...
Business Wire

Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Next-Generation Oral Testosterone Replacement Therapy in Male Patients With Hypogonadism

RALEIGH, N.C.--(BUSINESS WIRE)--Marius Pharmaceuticals, a specialty pharmaceutical company focusing on treating conditions that are primarily associated with testosterone deficiency, today announced ...
California Healthline

Procter & Gamble Withdraws FDA Application for Female Testosterone Patch

Proctor & Gamble has withdrawn an FDA application for its Intrinsa testosterone patch for female sexual dysfunction -- pre-empting "what many observers saw as a likely rejection" -- and announced ...